Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988-2011: A population-based observational study

Pediatric Blood and Cancer

Volumn 62, Issue 10, 2015, Pages 1819-1825

  Abrahão, Renata ^a,b   Lichtensztajn, Daphne Y ^b   Ribeiro, Raul C ^c   Marina, Neyssa M ^d   Keogh, Ruth H ^a   Marcos Gragera, Rafael ^e   Glaser, Sally L ^b,f   Keegan, Theresa H M ^b,f  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^e GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood; Leukemia; Population based; Race ethnicity; SES; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; ASIAN; BLACK PERSON; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CAUCASIAN; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HEALTH CARE DISPARITY; HISPANIC; HUMAN; IMMUNOPHENOTYPING; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEIGHBORHOOD; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; RISK FACTOR; SCHOOL CHILD; SOCIAL STATUS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT; NEWBORN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TRENDS;

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84939570261     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25544     Document Type: Article

References (35)

1. Smith MA, Seibel NL, Altekruse SF, Ries LAG, Melbert DL, O'Leary M, Smith FO, Reaman GH. Outcomes for children and adolescents with cancer: Challenges for the twenty-first century. J Clin Oncol 2010; 28:2625-2634.
2. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, Parkin M. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): An epidemiological study. Lancet 2004; 364:2097-2105.
3. Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer 2003; 97:2229-2235.
4. Yang W, Trevino LR, Yang JJ, Scheet P, Pui CH, Evans WE, Relling MV. ARID5B snp rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in Blacks and contributes to racial differences in leukemia incidence. Leukemia 2010; 24:894-896.
5. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, Camitta BM, Bowman WP, Willman CL, Carroll WL, Mullighan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML, Yang JJ. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst 2013; 105:733-742.
6. Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 2013; 50:185-196.
7. Goggins WB, Lo FFK. Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: Evidence from the SEER database 1988-2008. Cancer Causes Control 2012; 23:737-743.
8. Macdougall LG, Jankowitz P, Cohn R, Bernstein R. Acute childhood leukemia in Johannesburg. Ethnic differences in incidence, cell type, and survival. Am J Pediatr Hematol Oncol 1986; 8:43-51.
9. Lim JY, Bhatia S, Robison LL, Yang JJ. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer 2014; 120:955-962.
10. Lee B, Iceland J, Sharp G. Racial and Ethnic Diversity Goes Local: Charting Change in American Communities Over Three Decades. Rhode Island: Brown University; 2012.
11. World Health Organization. International Classification of Disease for Oncology, third edition; 2000.
12. Ruhl J, Adamo M, Dickie L. Hematopoietic and Lymphoid Neoplasm Coding Manual. Bethesda, MD: National Cancer Institute; 2015. p. 25-29.
13. Schmiegelow K, Levinsen MF, Attarbaschi A, Baruchel A, Devidas M, Escherich G, Gibson B, Heydrich C, Horibe K, Ishida Y, Liang DC, Locatelli F, Michel G, Pieters R, Piette C, Pui CH, Raimondi S, Silverman L, Stanulla M, Stark B, Winick N, Valsecchi MG. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2013; 31:2469-2476.
14. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001; 12:703-711.
15. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 1992; 82:703-710.
16. Tao L, Foran JM, Clarke CA, Gomez SL, Keegan TH. Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era. Blood 2014; 123:3553-3562.
17. Children's Hospital Association. http://www.childrenshospitals.net. Accessed June 22, 2014.
18. Children's Oncology Group (COG). http://www.childrensoncologygroup.org. Accessed July 10, 2014.
19. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360:2730-2741.
20. Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 2003; 290:2008-2014.
21. Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002; 100:1957-1964.
22. Bhatia S, Landier W, Hageman L, Kim H, Chen Y, Crews KR, Evans WE, Bostrom B, Casillas J, Dickens DS, Maloney KW, Neglia JP, Ravindranath Y, Ritchey AK, Wong FL, Relling MV. Adherence to oral 6-mercaptopurine in African, American and Asian children with acute lymphoblastic leukemia: A Children's Oncology Group study. Blood 2014; 2345-2353:23.
23. Meadows AT, Kramer S, Hopson R, Lustbader E, Jarrett P, Evans AE. Survival in childhood acute lymphocytic leukemia: Effect of protocol and place of treatment. Cancer Invest 1983; 1:49-55.
24. Gatta G, Capocaccia R, Stiller CA, Kaatsch P, Berrino F, Terenziani M. Childhood cancer survival trends in Europe: A EUROCARE working group study. J Clin Oncol 2005; 23:3742-3751.
25. De Angelis C, Pacheco C, Lucchini G, Arguello M, Conter V, Flores A, Biondi A, Masera G, Baez F. The experience in Nicaragua: Childhood leukemia in low-income countries-the main cause of late diagnosis may be "medical delay". Int J Pediatr 2012; 2012:129707.
26. Dang-Tan T, Trottier H, Mery LS, Morrison HI, Barr RD, Greenberg ML, Franco EL. Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer 2008; 51:468-474.
27. Fajardo-Gutierrez A, Sandoval-Mex AM, Mejia-Arangure JM, Rendon-Macias ME, Martinez-Garcia Mdel. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol 2002; 39:25-31.
28. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3:1590-1595.
29. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund JT, Rivera GK, Evans WE, Relling MV, Pui CH. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 2007; 297:1207-1215.
30. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sanchez-Perez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R. Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15:35-47.
31. Pui CH, Pei D, Sandlund JT, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Campana D, Kun LE, Jeha S, Cheng C, Howard SC, Metzger ML, Bhojwani D, Downing JR, Evans WE, Relling MV. Long-term results of St. Jude total therapy studies 11, 12, 13a, 13b, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010; 24:371-382.
32. Locatelli F, Moretta F, Rutella S. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches. Curr Opin Oncol 2013; 25:707-715.
33. Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, Kang H, Liu W, Dobbin KK, Smith MA, Carroll WL, Devidas M, Bowman WP, Camitta BM, Reaman GH, Hunger SP, Downing JR, Willman CL. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 2010; 115:5312-5321.
34. Pui CH, Pei D, Pappo AS, Howard SC, Cheng C, Sandlund JT, Furman WL, Ribeiro RC, Spunt SL, Rubnitz JE, Jeha S, Hudson MM, Kun LE, Merchant TE, Kocak M, Broniscer A, Metzger ML, Downing JR, Leung W, Evans WE, Gajjar A. Treatment outcomes in Black and White children with cancer: Results from the SEER database and St. Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol 2012; 30:2005-2012.
35. Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster JES, Lim JY, Chen IM, Fan Y, Devidas M, Borowitz MJ, Smith C, Neale G, Burchard EG, Torgerson DG, Klussmann FA, Villagran CR, Winick NJ, Camitta BM, Raetz E, Wood B, Yue F, Carroll WL, Larsen E, Bowman WP, Loh ML, Dean M, Bhojwani D, Pui CH, Evans WE, Relling MV, Hunger SP, Willman CL, Mullighan CG, Yang JJ. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 2013; 45:1494-1498.